Mojtaba Ghadiany1, Hamid Attarian, Abbas Hajifathali, Adnan Khosravi, Saatat Molanaee. Show Affiliations » 1. Department of Medical Oncology and Hematology, Taleghani Hospital, Shahid Beheshti University (MC), Tehran, Iran. mghadiany@taleghanihospital.ir
Abstract
Entities: Disease
Mesh: See more » Antimetabolites, Antineoplastic/therapeutic useCytarabine/therapeutic useDaunorubicin/therapeutic useHumansImmunohistochemistryLeukemia, Myeloid, Acute/drug therapyLeukemia, Myeloid, Acute/pathologyMaleMiddle AgedOrchiectomyRecurrenceRemission InductionSarcoma, Myeloid/pathologySarcoma, Myeloid/surgeryTesticular Neoplasms/pathologyTesticular Neoplasms/surgery
Substances: See more » Antimetabolites, AntineoplasticCytarabineDaunorubicin
Year: 2008 PMID: 18592470
Source DB: PubMed Journal: Urol J ISSN: 1735-1308 Impact factor: 1.510